domingo, 22 de agosto de 2021

FDA Publishes Revised Draft Guidance for Industry, Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA - Drug Information Update

download

No hay comentarios:

Publicar un comentario